Cardiology

Re-analysis of diabetes drug finds no higher heart attack risk

A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute ...

Medications

US experts review heart attack risk of diabetes drug

GlaxoSmithKline's controversial diabetes drug Avandia, restricted in the US and banned in Europe over concerns it raises heart attack risk, is getting a second look this week by US medical experts.

Cardiology

RELAX-AHF shows first positive findings in HFpEF patients

Serelaxin may be more effective for relieving dyspnea in heart failure with preserved ejection fraction (HFpEF) than reduced (HFrEF) during the first 24 hours, according to results from RELAX-AHF presented in today's late ...

Health

Tart cherries linked to reduced risk of stroke

(Medical Xpress)—For the millions of Americans at risk for heart disease or diabetes, a diet that includes tart cherries might actually be better than what the doctor ordered, according to new animal research from the University ...

Health

FDA warns consumers of dangers of the stimulant DMAA

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated with these ...

Health

FDA urged to curb caffeine in energy drinks

(Medical Xpress)—A group of doctors and public health experts are urging the Food and Drug Administration (FDA) to take immediate action to protect young people from the effects of caffeinated energy drinks. In a letter ...

page 17 from 29